The EU CE mark for the companies’ AI-powered AiMIFY software for enhancing contrast MRI scans follows its FDA clearance in ...

Innovation in clinical diagnostics is accelerating, with breakthroughs that promise to make testing more precise, less invasive and more accessible. These advancements are expected not only to benefit ...

A team at the University of California, Los Angeles has developed a low-cost diagnostic pen that converts handwriting into ...

Highly pathogenic avian influenza reached Antarctica’s mainland in early 2024, leaving Australia, New Zealand and Pacific ...

The successful use of QDs has been reported in the areas of in vitro diagnostics and imaging ... can be used to adapt them for use in different clinical applications. QDs have been successfully ...

In conclusion, the diagnosis of IgG4-RD is complex and usually requires a combination of clinical analyses, imaging, histological and serological examination. No finding alone is specific to IgG4-RD.

Researchers compared their long-standing diagnostic decision support systems AI tool, DXplain, with modern large language models like ChatGPT and Gemini, finding DXplain performed slightly better.

The widespread adoption of its TruCytes™ and SpectraComp® products across research, clinical trials, diagnostics, and cell therapy applications is driving the company to expand its commercial ...

Diagnostic downshift incurs costs as commissioners procure supply beyond current capacity, potentially fragmenting care across additional providers, often without clinical or information technology ...

1 Table 2. Applying American College of Cardiology/American Heart Association Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in ...